Randomized controlled study of the influence of two low estrogen dose oral contraceptives containing gestodene or desogestrel on carbohydrate metabolism

Contraception

Volumn 66, Issue 6, 2002, Pages 411-415

  Lüdicke, Frank ^a   Gaspard, Ulysse J ^b   Demeyer, Fabienne ^b   Scheen, A ^b   Lefebvre, P ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Carbohydrate; Estrogen; Glucose; Insulin; Oral contraceptive; Progestogen

Indexed keywords

ANDROGEN; C PEPTIDE; DESOGESTREL; DESOGESTREL PLUS ETHINYLESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS GESTODENE; GESTODENE; GLUCOSE; INSULIN; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; CARBOHYDRATE METABOLISM; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN EXPERIMENT; LOW DRUG DOSE; STATISTICAL SIGNIFICANCE;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; CONTRACEPTIVES, ORAL, COMBINED; DESOGESTREL; ETHINYL ESTRADIOL; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; NORPREGNENES; UTERINE HEMORRHAGE;

EID: 0242286063     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(02)00415-8     Document Type: Article

References (21)

1. Godsland I.F. The influence of female sex steroids on glucose metabolism and insulin action. J Intern Med. 240:(Suppl. 738):1996;1-60.
2. Paulus D., Saint-Remy A., Jeanjean M. Oral contraception and cardiovascular risk factors during adolescence. Contraception. 62:2000;113-116.
3. Kuhl H. Comparative pharmacology of newer progestogens. Drugs. 51:1996;188-215.
4. Gaspard U.J., Wery O.J., Scheen A.J., Jaminet C., Lefebvre P.J. Long-term effects of oral estradiol and dydrogesterone on carbohydrate metabolism in postmenopausal women. Climacteric. 2:1999;93-100.
5. Rimm E.B., Manson J.E., Stampfer M.J., et al. Oral contraceptive use and the risk of type 2 (non-insulin-dependent) diabetes mellitus in a large prospective study of women. Diabetologia. 35:1992;967-972.
6. Oral contraceptives no apparent association with diabetic complications . Worlds Drug Information. 8:1994;135-136.
7. Gaspard U.J., Lefebvre P.J. Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease. Am J Obstet Gynecol. 163:1990;334-343.
8. Despres J.P., Lamarche B., Mauriege P., et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 334:1996;952-957.
9. Fahmy K., Abdel-Razik M., Shaaraway M., et al. Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile. Contraception. 44:1991;419-430.
10. Shamma F.N., Rossi G., HajHassan L., et al. The effect of Norplant on glucose metabolism under hyperglycemic hyperinsulinemic conditions. Fertil Steril. 63:1995;767-772.
11. Spellacy W.N., Buhi W.C., Birk S.A. The effects of norgestrel on carbohydrate and lipid metabolism over one year. Am J Obstet Gynecol. 125:1976;984-986.
12. Kojima T., Lindheim S.R., Duffy D.M., et al. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives. Am J Obstet Gynecol. 169:1993;1540-1544.
13. Godsland I.F., Walton C., Felton C., et al. Insulin resistance, secretion, and metabolism in users of oral contraceptives. J Clin Endocrinol Metab. 74:1992;64-70.
14. Crook D., Godsland I. Safety evaluation of modern oral contraceptives. Effects on lipoprotein and carbohydrate metabolism. Contraception. 57:1998;189-201.
15. Fioretti P., Fruzzetti F., Navalesi R., et al. Clinical and metabolic effects of a pill containing 30 mcg ethinylestradiol plus 75 mcg gestodene. Contraception. 40:1989;649-663.
16. Petersen K.R., Skouby S.O., Pedersen R.G. Desogestrel and gestodene in oral contraceptives 12 months' assessment of carbohydrate and lipoprotein metabolism . Obstet Gynecol. 78:1991;666-672.
17. Spellacy W.N., Tsibris A.M., Tsibris J.C., George S., Chez R.A., O'Brien W.F. Carbohydrate metabolism studies after one year of using an oral contraceptive containing gestodene and ethinyl estradiol. Contraception. 49:1994;125-130.
18. Miccoli R., Orlandi M.C., Fruzzetti F., et al. Metabolic effects of three new low-dose pills a six-month experience . Contraception. 39:1989;643-652.
19. van den Ende A., Lütjens A., van Wayjen R.G.A., Kloosterboer H.J. Effects of the oral contraceptive combination 0.150 mg desogestrel plus 0.020 mg ethinylestradiol on carbohydrate metabolism in healthy female volunteers. Acta Obstet Gynecol Scand. 144:(Suppl):1987;29-32.
20. Fioretti P., Fruzzetti F., Navalesi R., et al. Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel. Contraception. 35:1987;229-243.
21. Godsland I.F., Crook D., Worthington M., et al. Effects of a low-estrogen, desogestrel-containing oral contraceptive on lipid and carbohydrate metabolism. Contraception. 48:1993;217-227.